G protein-coupled receptors: potential therapeutic targets for diabetic nephropathy

被引:2
作者
Ding, Hai-Hua [1 ,2 ]
Ni, Wei-Jian [2 ]
Tang, Li-Qin [2 ]
Wei, Wei [1 ]
机构
[1] Anhui Med Univ, Key Lab Antiinflammatory & Immune Med, Anhui Collaborat Innovat Ctr Antiinflammatory & I, Minist Educ,Inst Clin Pharmacol, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China
[2] Anhui Med Univ, Affiliated Anhui Prov Hosp, 17 Lujiang Rd, Hefei 230001, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
Diabetic nephropathy; G protein-coupled receptors; signaling pathways; therapeutic target; ANGIOTENSIN-II TYPE-1; CANNABINOID RECEPTOR; KIDNEY-DISEASE; ADENOSINE RECEPTORS; SIGNALING PATHWAY; MESANGIAL CELLS; ACTIVATION; EXPRESSION; INHIBITION; ENDOTHELIN;
D O I
10.3109/10799893.2015.1122039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic nephropathy, a lethal microvascular complication of diabetes mellitus, is characterized by progressive albuminuria, excessive deposition of extracellular matrix, thickened glomerular basement membrane, podocyte abnormalities, and podocyte loss. The G protein-coupled receptors (GPCRs) have attracted considerable attention in diabetic nephropathy, but the specific effects have not been elucidated yet. Likewise, abnormal signaling pathways are closely interrelated to the pathologic process of diabetic nephropathy, despite the fact that the mechanisms have not been explored clearly. Therefore, GPCRs and its mediated signaling pathways are essential for priority research, so that preventative strategies and potential targets might be developed for diabetic nephropathy. This article will give us comprehensive overview of predominant GPCR types, roles, and correlative signaling pathways in diabetic nephropathy.
引用
收藏
页码:411 / 421
页数:11
相关论文
共 55 条
[1]  
Akazawa H, 2013, CURR PHARM DESIGN, V19, P2988
[2]   Activation of adenosine 2A receptors preserves structure and function of podocytes [J].
Awad, Alaa S. ;
Rouse, Michael ;
Liu, Lixia ;
Vergis, Amy L. ;
Rosin, Diane L. ;
Linden, Joel ;
Sedor, John R. ;
Okusa, Mark D. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (01) :59-68
[3]   Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice [J].
Barutta, Federica ;
Grimaldi, Serena ;
Franco, Irene ;
Bellini, Stefania ;
Gambino, Roberto ;
Pinach, Silvia ;
Corbelli, Alessandro ;
Bruno, Graziella ;
Rastaldi, Maria Pia ;
Aveta, Teresa ;
Hirsch, Emilio ;
Di Marzo, Vincenzo ;
Gruden, Gabriella .
KIDNEY INTERNATIONAL, 2014, 86 (05) :979-990
[4]   Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy [J].
Barutta, Federica ;
Piscitelli, Fabiana ;
Pinach, Silvia ;
Bruno, Graziella ;
Gambino, Roberto ;
Rastaldi, Maria Pia ;
Salvidio, Gennaro ;
Di Marzo, Vincenzo ;
Perin, Paolo Cavallo ;
Gruden, Gabriella .
DIABETES, 2011, 60 (09) :2386-2396
[5]   Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy [J].
Barutta, Federica ;
Corbelli, Alessandro ;
Mastrocola, Raffaella ;
Gambino, Roberto ;
Di Marzo, Vincenzo ;
Pinach, Silvia ;
Rastaldi, Maria Pia ;
Perin, Paolo Cavallo ;
Gruden, Gabriella .
DIABETES, 2010, 59 (04) :1046-1054
[6]   Adenosine A2B receptor-mediated VEGF induction promotes diabetic glomerulopathy [J].
Cardenas, Angel ;
Toledo, Camilo ;
Oyarzun, Carlos ;
Sepulveda, Angelica ;
Quezada, Claudia ;
Guillen-Gomez, Elena ;
Diaz-Encarnacion, Montserrat M. ;
Pastor-Anglada, Marcal ;
San Martin, Rody .
LABORATORY INVESTIGATION, 2013, 93 (01) :135-144
[7]   Apelin retards the progression of diabetic nephropathy [J].
Day, Robert T. ;
Cavaglieri, Rita C. ;
Feliers, Denis .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2013, 304 (06) :F788-F800
[8]   G Protein-Coupled Receptors and Adipogenesis: A Focus on Adenosine Receptors [J].
Eisenstein, Anna ;
Ravid, Katya .
JOURNAL OF CELLULAR PHYSIOLOGY, 2014, 229 (04) :414-421
[9]  
Elsherbiny Nehal M., 2013, Inflammation & Allergy Drug Targets, V12, P153
[10]   Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases [J].
Eremina, V ;
Sood, M ;
Haigh, J ;
Nagy, A ;
Lajoie, G ;
Ferrara, N ;
Gerber, HP ;
Kikkawa, Y ;
Miner, JH ;
Quaggin, SE .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) :707-716